Skip to main content
. 2020 Feb 24;60(6):317–325. doi: 10.4103/nmj.NMJ_2_19

Table 1.

Severity rating of the interactions between drugs indicated for renal dysfunction and co-administered drugs

Rating Designation Action Explanation
A Unknown No known interaction Unknown
B Minor No action needed The interaction would have limited clinical effects. May include an increase in the frequency or severity of the side effects but generally would not require a major alteration in therapy
C Moderate Monitor therapy The interaction may result to exacerbation of the patient’s condition and/or require an alteration in therapy
D Major Therapy modification The interaction may be life threatening and/or require medical serious adverse events
X Contraindicated Avoid combination The drugs are contraindicated for concurrent use

A and B are considered nonclinically significant drug interactions, whereas C, D, and X are considered clinically significant drug interactions